Semin Liver Dis 2001; 21(2): 213-224
DOI: 10.1055/s-2001-15497
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Imaging Evaluation of the Cirrhotic Liver

Takamichi Murakami1 , Kiyoshi Mochizuki2 , Hironobu Nakamura1
  • 1Department of Diagnostic Medicine (Radiology), Osaka University Graduate School of Medicine, Osaka, Japan
  • 2Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
Further Information

Publication History

Publication Date:
31 December 2001 (online)

ABSTRACT

Because recent advances in medical care decrease the mortality rate due to liver cirrhosis itself, many cirrhotic patients die due to hepatocellular carcinoma. Accordingly, the role of radiology in the evaluation of the patient with cirrhosis is primarily to characterize the morphologic manifestations of the disease, evaluate the hepatic and extrahepatic vasculature, assess the effects of portal hypertension, and detect hepatic tumors. When the latter are identified, a critical role of imaging technology is to differentiate hepatocellular carcinoma from other nodular lesions, such as dysplastic nodules and regenerating nodules.

Screening strategies for patients with cirrhosis have been proposed to facilitate the detection of small, asymptomatic hepatocellular carcinomas. Dynamic studies using computed tomography (CT) and magnetic resonance imaging (MRI) are very useful for the diagnosis of hepatic tumors previously detected by ultrasound, as well as for screening. In Japan, patients with documented cirrhosis typically undergo serum alpha-fetoprotein testing and/or PIVKA-II (protein induced by vitamin K absence or antagonist II) measurements every 2 months, ultrasound every 3 months, and CT or MRI every 6 months. This has resulted in great success in detecting small hepatocellular carcinomas (less than 2 cm in diameter) and early-stage well-differentiated hepatocellular carcinomas.

REFERENCES

  • 1 Podolsky D K, Isselbacher K J. Alcohol-related liver disease and cirrhosis. In: Isselbacher KJ, Braunwald E, Wilson JD, et al., eds. Harrison's Principles of Internal Medicine, 13th ed New York: McGraw-Hill, 1994: 1483-1495
  • 2 Conn H O, Atterbury C E. Cirrhosis. In: Schiff L, Schiff ER, eds. Diseases of the Liver, 7th ed Philadelphia: Lippincott; 1993 ;875-934
  • 3 Genesca J, Esteban J I, Alter H J. Blood-borne non-A, non-B hepatitis: hepatitis C.  Semin Liver Dis . 1991;  11 147-164
  • 4 Ince N, Wands J R. The increasing incidence of hepatocellular carcinoma.  N Engl J Med . 1999;  340 798-799
  • 5 Kobayashi K, Sugimoto T, Makino H. Screening methods for early detection of hepatocellular carcinoma.  Hepatology . 1985;  5 1100-1105
  • 6 Oka H, Kurioka N, Kim K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.  Hepatology . 1990;  12 680-687
  • 7 Popper H. Pathologic aspects of cirrhosis: a review.  Am J Pathol . 1977;  87 228-264
  • 8 Brown J J, Naylor M J, Yagan N. Imaging of hepatic cirrhosis.  Radiology . 1997;  202 1-16
  • 9 Laennec R TH. Traite de l'auscultation medicale. Paris, France:Chaude, 1826: 196
  • 10 Harbin W P, Robert N J, Ferrucci Jr T J. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis.  Radiology . 1980;  135 273-283
  • 11 Freeman M P, Vick C W, Taylor K JW. Regenerating nodules in cirrhosis: sonographic appearance with anatomic correlation.  AJR . 1986;  146 533-536
  • 12 Murakami T, Nakamura H, Hori S. CT and MRI of siderotic regenerating nodules in cirrhotic liver.  J Comput Assist Tomogr . 1992;  16 578-582
  • 13 Itai Y, Ohnishi S, Ohtomo K. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation.  AJR . 1987;  165 419-423
  • 14 Ohtomo K, Itai Y, Ohtomo Y, Shiga J, Ito M. Regeneration nodules of liver cirrhosis: MR imaging with pathologic correlation.  AJR . 1990;  154 505-507
  • 15 Murakami T, Kuroda C, Marukawa T. Regenerating nodules of hepatic cirrhosis: MR findings with pathologic correlation.  AJR . 1990;  155 1227-1231
  • 16 Ohtomo K, Baron R L, Dodd III D G. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT.  Radiology . 1993;  188 31-35
  • 17 Ralls P W. Color Doppler sonography of the hepatic artery and portal venous system.  AJR . 1990;  155 522-526
  • 18 Middleton W D. The liver. In: Kurtz AB, Middleton, eds. Ultrasound: the requisites St. Louis: Mosby-Year Book, 1996: 3-34
  • 19 Bolondi L, Li Bassi S, Gaiani S. Liver cirrhosis: changes of Doppler waveform of hepatic veins.  Radiology . 1991;  178 513-516
  • 20 Edelman R R, Zhao B, Liu C. MR angiography and dynamic flow evaluation of the portal venous system.  AJR . 1989;  153 755-760
  • 21 Finn J P, Kane R A, Edelman R R. Imaging of the portal venous system in patients with cirrhosis: MR angiography versus duplex Doppler sonography.  AJR . 1993;  161 989-994
  • 22 Minami M, Itai Y, Ohtomo K. Siderotic nodules in the spleen: MR imaging of portal hypertension.  Radiology . 1989;  172 681-684
  • 23 Kondo F, Ebara M, Sugiura N. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality.  Hepatology . 1990;  12 592-598
  • 24 Liver cancer study group of Japan. General rules for the clinical and pathological study of primary liver cancer Tokyo: Kanehara, 1992: 14-17
  • 25 Craig J R, Klatt E C, Yu M. Role of cirrhosis and the development of HCC: evidence from histologic studies and large population studies. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America The Woodlands, TX: Portfolio 1991: 177-190
  • 26 Calvet X, Bruix J, Bru C. Natural history of hepatocellular carcinoma in Spain.  J Hepatol . 1990;  10 311-317
  • 27 Zaman S N, Johnson P J, Williams R. Silent cirrhosis in patients with hepatocellular carcinoma: implications for screening in high-incidence and low-incidence areas.  Cancer . 1990;  65 1607-1610
  • 28 Tribelli C, Melato M, Croce L S. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world-Trieste, Italy, and Chiba, Japan.  Hepatology . 1989;  10 998-1002
  • 29 El-Serag H B, Mason A C. Rising incidence of hepatocellular carcinoma in the United States.  N Engl J Med . 1999;  340 745-750
  • 30 Nzeako V C, Goodman Z D, Ishak K G. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers: a clinico- histopatholgoic study of 804 North American patients.  Am J Clin Pathol . 1996;  105 65-75
  • 31 Okuda K. Hepatocellular carcinoma in cirrhotics.  Semin Liver Dis . 1993;  13 374-383
  • 32 Alpert E, Hershberg R, Schur P H. Alpha fetoprotein in human hepatoma: improved detection in serum and quantitative studies using a new sensitive technique.  Gastroenterology . 1971;  61 137-143
  • 33 Tanaka S, Kitamura T, Imaoka S. Hepatocellular carcinoma: sonographic and histologic correlation.  AJR . 1983;  140 701-707
  • 34 Dodd III D G, Miller W J, Baron R L, Kolnick M L, Campbell W L. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening tool.  AJR . 1992;  159 727-733
  • 35 Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors.  AJR . 1990;  154 509-514
  • 36 Tanaka S, Kitamura T, Fujita M. Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging.  Radiology . 1992;  182 161-165
  • 37 Tochio H, Minowa K, Tomita S. Differential diagnosis of hepatic tumors using color Doppler flow imaging: value of the Doppler spectral analysis.  Jpn J Med Ultrasonics . 1992;  19 277-287
  • 38 Nanda N C, Schlief R. Advances in Echo Imaging Using Contrast Enhancement.  Dordrecht, the Netherlands: Kluwer Academic Publishers; 1993
  • 39 Fujimoto M, Moriyasu F, Nishikawa K. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: Correlation with angiographic findings.  AJR . 1994;  163 1099-1104
  • 40 Yamashita Y, Takahashi M, Baba Y. Hepatocellular carcinoma with or without cirrhosis: a comparison of CT and angiographic presentations in the United States and Japan.  Abdom Imaging . 1993;  18 168-175
  • 41 Kim T, Murakami T, Oi H. Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT.  J Comput Assist Tomogr . 1995;  19 948-954
  • 42 Mitsuzaki K, Yamashita Y, Ogata I, Nishiharu T, Urata J, Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.  AJR . 1996;  167 753-757
  • 43 Earls J, Rofsky N R, DeCorato D. Arterial-phase dynamic gadolinium-enhanced MR imaging: optimizing with a test examination and a power injector.  Radiology . 1997;  202 268-273
  • 44 Kelekis N L, Semelka R C, Worawattanakul S. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.  AJR . 1998;  170 1005-1013
  • 45 Itai Y, Matsui O. Blood flow and liver imaging.  Radiology . 1997;  202 306-314
  • 46 Matsui O, Kadoya M, Yoshikawa J. Aberrant gastric venous drainage in cirrhotic livers: imaging findings in focal areas of liver parenchyma.  Radiology . 1995;  197 345-349
  • 47 Mitani T, Nakamura H, Murakami T. Dynamic MR studies of hepatocellular carcinoma with portal vein tumor thrombosis.  Radiation Medicine . 1992;  10 232-234
  • 48 Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histologic findings.  Radiology . 1992;  183 819-825
  • 49 Itai Y, Ohtomo K, Furui S, Minami M, Yoshikawa K, Yashiro N. Lobar intensity differences of the liver on MR imaging.  J Comput Assist Tomogr . 1986;  10 236-241
  • 50 Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice.  Radiology . 1994;  193 593-595
  • 51 Murakami T, Baron R L, Federle M P. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).  Radiology . 1996;  200 69-77
  • 52 Imai Y, Murakami T, Yoshida S. Superparamagnetic iron oxide-enhanced MR images of hepatocellular carcinoma: correlation with histological grading.  Hepatology . 2000;  32 205-212
  • 53 International working party. Terminology of nodular hepatocellular lesions.  Hepatology . 1995;  22 983-993
  • 54 Hytiroglou P, Theis N D. Differential diagnosis of hepatocellular nodular lesions.  Semin Diagn Pathol . 1998;  15 285-299
  • 55 Mitchell D G. Focal manifestations of diffuse liver disease at MR imaging.  Radiology . 1992;  185 1-11
  • 56 Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.  Hum Pathol . 1991;  22 172-178
  • 57 Lim J H, Kim C K, Lee W J. Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients.  AJR . 2000;  175 693-698
  • 58 Matsui O, Kadoya M, Kameyama T. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.  Radiology . 1991;  178 493-497
  • 59 Lim J H, Kim E Y, Lee W J. Regenerating nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation.  Radiology . 1999;  210 451-458
  • 60 Ebara M, Ohto M, Waranabe Y. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies.  Radiology . 1986;  159 371-377
  • 61 Ebara M, Fukuda H, Kojima Y. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma.  Radiology . 1999;  210 81-88
  • 62 Sedek A G, Mitchell D G, Siegelman E S. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging.  Radiology . 1995;  195 753-756
  • 63 Oka H, Kurioka N, Kanno T. Prospective study of early detection of hepatocellular carcinoma in patient with cirrhosis.  Hepatology . 1990;  12 680-687
  • 64 Arii S, Tobe T. Results of surgical treatment. Follow-up study by liver cancer study group of Japan In: Tobe T, et al, eds. Primary Liver Cancer in Japan Tokyo: Springer-Verlag 1992: 243-255
  • 65 Tanaka S, Kitamura T, Nakanishi K. Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma.  Cancer . 1989;  63 1313-1317
  • 66 Ebara M, Ohto M, Shinagawa T. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: a study in 22 patients.  Gastroenterology . 1986;  90 289-298
  • 67 Kaneko S, Unoura M, Kobayashi K. Early detection of hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver Cancer New York: Churchill Livingstone 1997: 393-406
    >